Invesco
ABEO icon

Invesco’s Abeona Therapeutics ABEO Stock Holding History

Invesco’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103K Sell
22,979
-81
-0.4% -$405 ﹤0.01% 3621
2025
Q4 		$122K Buy
23,060
+49
+0.2% +$247 ﹤0.01% 3617
2025
Q3 		$121K Buy
23,011
+96
+0.4% +$609 ﹤0.01% 3659
2025
Q2 		$130K Buy
+22,915
New +$130K ﹤0.01% 3612
2021
Q2 		– Sell
-453
Closed -$21K – 3957
2021
Q1 		$21K Buy
+453
New +$25K ﹤0.01% 3847
2020
Q2 		– Sell
-2,405
Closed -$126K – 3635
2020
Q1 		$126K Buy
+2,405
New +$161K ﹤0.01% 3516
2018
Q4 		– Sell
-4,881
Closed -$1.56M – 3812
2018
Q3 		$1.56M Sell
4,881
-217
-4% -$77K ﹤0.01% 2922
2018
Q2 		$2.04M Buy
+5,098
New +$2.23M ﹤0.01% 2744
2018
Q1 		– Sell
-8,619
Closed -$3.42M – 3707
2017
Q4 		$3.42M Buy
+8,619
New +$3.56M ﹤0.01% 2216
2017
Q3 		– Sell
-459
Closed -$73K – 3645
2017
Q2 		$73K Sell
459
-38
-8% -$5.18K ﹤0.01% 3657
2017
Q1 		$62K Buy
+497
New +$64.1K ﹤0.01% 3673
2015
Q3 		– Sell
-32
Closed -$4K – 3779
2015
Q2 		$4K Buy
+32
New +$4.81K ﹤0.01% 4275

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco's ABEO Position: Q1 2026 in Review

Invesco reduced its Abeona Therapeutics (ABEO) stake by 0.35% in Q1 2026, selling an estimated $405 and leaving 22,979 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #3621.

Invesco first reported a position in ABEO in Q2 2015 and has held it in 12 quarters since. The position peaked at $3.42M in Q4 2017. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Invesco held 22,979 shares of Abeona Therapeutics worth $103K as of Q1 2026.
  • Invesco sold 81 Abeona Therapeutics shares in Q1 2026, an estimated $405.
  • Abeona Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3621 holding.
  • Invesco first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 12 quarters since.
  • Invesco's Abeona Therapeutics position peaked at $3.42M in Q4 2017.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.